
Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

